Radiopharm Theranostics

1:45 PM - 2:00 PM (EST), Monday, February 6, 2023 ・ Music Box
Clinical and preclinical stage company focusing on Radiopharmaceuticals Imaging and Therapies in Oncology. Deep pipeline of differentiated and innovative molecules
Ticker:
RAD
Exchange:
ASX
Company Type:
Publicly Traded Company
Company HQ State:
Not Provided
Company HQ Country:
Australia
Year Founded:
2021
Main Therapeutic Focus:
Oncology
Lead Product in Development:
Pivalate
Development Phase of Primary Product:
Phase II
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Radiopharm Theranostics